TY - JOUR
T1 - Rationale and design of the research project of the South Florida Center for the Reduction of Cancer Health Disparities (SUCCESS)
T2 - Study protocol for a randomized controlled trial
AU - Carrasquillo, Olveen
AU - McCann, Sheila
AU - Amofah, Antony
AU - Pierre, Larry
AU - Rodriguez, Brendaly
AU - Alonzo, Yisel
AU - Ilangovan, Kumar
AU - Gonzalez, Martha
AU - Trevil, Dinah
AU - Byrne, Margaret M.
AU - Koru-Sengul, Tulay
AU - Kobetz, Erin
N1 - Publisher Copyright:
© 2014 Carrasquillo et al.; licensee BioMed Central Ltd.
Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 2014/7/23
Y1 - 2014/7/23
N2 - Background: In the United States certain minority groups, such as racial/ethnic immigrant women, are less likely than non-Hispanic White women to be screened for cervical cancer. Barriers to such care include health insurance, cost, knowledge, attitudes, health literacy, and cultural norms and practices. Among the most promising approaches to increase screening in these groups are patient navigators that can link women to sources of appropriate care. Another recent promising approach is using human papilloma virus (HPV) self-sampling. In this manuscript, we describe our National Cancer Institute-sponsored study testing such approaches among immigrant minority women.Design: The South Florida Center for the Reduction of Cancer Health Disparities (SUCCESS) is conducting a three-arm randomized trial among Hispanic, Haitian, and African American women in Miami-Dade County. Community health workers (CHW) based in each of three communities are recruiting 200 women at each site (600 total). Eligibility criteria include women aged 30-65 years who have not had a Pap smear test in the last 3 years. Prior to randomization, all women undergo a standardized structured interview. Women randomized to public health outreach, Group 1, receive culturally tailored educational materials. Women in Group 2 receive an individualized comprehensive cervical cancer CHW-led education session followed by patient navigation to obtain the Pap smear test at community-based facilities. Women in Group 3 have the option of navigation to a Pap smear test or performing HPV self-sampling. The primary outcome is self-report of completed screening through a Pap smear test or HPV self-sampling within 6 months after enrollment.Discussion: SUCCESS is one of the first trials testing HPV self-sampling as a screening strategy among underserved minority women. If successful, HPV self-sampling may be an important option in community outreach programs aimed at reducing disparities in cervical cancer. Trial registration: Clinical Trials.gov # NCT02121548, registered April 21, 2014.
AB - Background: In the United States certain minority groups, such as racial/ethnic immigrant women, are less likely than non-Hispanic White women to be screened for cervical cancer. Barriers to such care include health insurance, cost, knowledge, attitudes, health literacy, and cultural norms and practices. Among the most promising approaches to increase screening in these groups are patient navigators that can link women to sources of appropriate care. Another recent promising approach is using human papilloma virus (HPV) self-sampling. In this manuscript, we describe our National Cancer Institute-sponsored study testing such approaches among immigrant minority women.Design: The South Florida Center for the Reduction of Cancer Health Disparities (SUCCESS) is conducting a three-arm randomized trial among Hispanic, Haitian, and African American women in Miami-Dade County. Community health workers (CHW) based in each of three communities are recruiting 200 women at each site (600 total). Eligibility criteria include women aged 30-65 years who have not had a Pap smear test in the last 3 years. Prior to randomization, all women undergo a standardized structured interview. Women randomized to public health outreach, Group 1, receive culturally tailored educational materials. Women in Group 2 receive an individualized comprehensive cervical cancer CHW-led education session followed by patient navigation to obtain the Pap smear test at community-based facilities. Women in Group 3 have the option of navigation to a Pap smear test or performing HPV self-sampling. The primary outcome is self-report of completed screening through a Pap smear test or HPV self-sampling within 6 months after enrollment.Discussion: SUCCESS is one of the first trials testing HPV self-sampling as a screening strategy among underserved minority women. If successful, HPV self-sampling may be an important option in community outreach programs aimed at reducing disparities in cervical cancer. Trial registration: Clinical Trials.gov # NCT02121548, registered April 21, 2014.
KW - Cervical cancer
KW - Community-based participatory research
KW - Haitian
KW - Health disparities
KW - Hispanic
KW - Human papilloma virus
KW - Immigrant
KW - Minority
KW - Screening
UR - http://www.scopus.com/inward/record.url?scp=84904534998&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84904534998&partnerID=8YFLogxK
U2 - 10.1186/1745-6215-15-299
DO - 10.1186/1745-6215-15-299
M3 - Article
C2 - 25056208
AN - SCOPUS:84904534998
VL - 15
JO - Trials
JF - Trials
SN - 1745-6215
IS - 1
M1 - 299
ER -